196 related articles for article (PubMed ID: 31075684)
41. Zebra sign specific to ALS or not.
Saleem S; Anwar A
J Neurol Sci; 2019 Aug; 403():30. PubMed ID: 31185433
[No Abstract] [Full Text] [Related]
42. Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot study.
Endo H; Sekiguchi K; Shimada H; Ueda T; Kowa H; Kanda F; Toda T
J Neurol; 2018 Mar; 265(3):552-561. PubMed ID: 29356968
[TBL] [Abstract][Full Text] [Related]
43. Transcallosal inhibition in amyotrophic lateral sclerosis.
Wittstock M; Wolters A; Benecke R
Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846
[TBL] [Abstract][Full Text] [Related]
44. Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis.
Jin J; Hu F; Zhang Q; Chen Q; Li H; Qin X; Jia R; Kang L; Dang Y; Dang J
Sci Rep; 2019 Dec; 9(1):20059. PubMed ID: 31882886
[TBL] [Abstract][Full Text] [Related]
45. Muscle histopathology in upper motor neuron-dominant amyotrophic lateral sclerosis.
Sorarù G; D'Ascenzo C; Nicolao P; Volpe M; Martignago S; Palmieri A; Romeo V; Koutsikos K; Piccione F; Cima V; Pegoraro E; Angelini C
Amyotroph Lateral Scler; 2008 Oct; 9(5):287-93. PubMed ID: 18608096
[TBL] [Abstract][Full Text] [Related]
46. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
Wang S; Melhem ER
Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
[TBL] [Abstract][Full Text] [Related]
47. Structural MRI correlates of amyotrophic lateral sclerosis progression.
Senda J; Atsuta N; Watanabe H; Bagarinao E; Imai K; Yokoi D; Riku Y; Masuda M; Nakamura R; Watanabe H; Ito M; Katsuno M; Naganawa S; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):901-907. PubMed ID: 28501822
[TBL] [Abstract][Full Text] [Related]
48. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
49. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
[TBL] [Abstract][Full Text] [Related]
50. Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: A multimodal MRI analysis.
Qiu T; Zhang Y; Tang X; Liu X; Wang Y; Zhou C; Luo C; Zhang J
Hum Brain Mapp; 2019 Aug; 40(12):3464-3474. PubMed ID: 31020731
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the upper motor neuron in amyotrophic lateral sclerosis.
Huynh W; Simon NG; Grosskreutz J; Turner MR; Vucic S; Kiernan MC
Clin Neurophysiol; 2016 Jul; 127(7):2643-60. PubMed ID: 27291884
[TBL] [Abstract][Full Text] [Related]
52. Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis.
Vázquez-Costa JF; Mazón M; Carreres-Polo J; Hervás D; Pérez-Tur J; Martí-Bonmatí L; Sevilla T
Acta Neurol Scand; 2018 Feb; 137(2):262-271. PubMed ID: 29082510
[TBL] [Abstract][Full Text] [Related]
53. Frontal lobe atrophy in motor neuron diseases.
Kiernan JA; Hudson AJ
Brain; 1994 Aug; 117 ( Pt 4)():747-57. PubMed ID: 7922462
[TBL] [Abstract][Full Text] [Related]
54. Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.
Moreno-Gambín MI; Tembl JI; Mazón M; Cañada-Martínez AJ; Martí-Bonmatí L; Sevilla T; Vázquez-Costa JF
J Neurol; 2022 Mar; 269(3):1631-1640. PubMed ID: 34379200
[TBL] [Abstract][Full Text] [Related]
55. Motor cortical patterns of upper motor neuron pathology in amyotrophic lateral sclerosis: A 3 T MRI study with iron-sensitive sequences.
Donatelli G; Costagli M; Cecchi P; Migaleddu G; Bianchi F; Frumento P; Siciliano G; Cosottini M
Neuroimage Clin; 2022; 35():103138. PubMed ID: 36002961
[TBL] [Abstract][Full Text] [Related]
56. Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.
Devine MS; Pannek K; Coulthard A; McCombe PA; Rose SE; Henderson RD
Neuroimage Clin; 2015; 7():782-7. PubMed ID: 25844330
[TBL] [Abstract][Full Text] [Related]
57. MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis.
Donatelli G; Caldarazzo Ienco E; Costagli M; Migaleddu G; Cecchi P; Siciliano G; Cosottini M
Neuroimage Clin; 2019; 24():101934. PubMed ID: 31377555
[TBL] [Abstract][Full Text] [Related]
58. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.
Sabatelli M; Zollino M; Luigetti M; Grande AD; Lattante S; Marangi G; Monaco ML; Madia F; Meleo E; Bisogni G; Conte A
Amyotroph Lateral Scler; 2011 Jul; 12(4):278-82. PubMed ID: 21702734
[TBL] [Abstract][Full Text] [Related]
59. MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.
Sako W; Izumi Y; Abe T; Haji S; Murakami N; Osaki Y; Matsumoto Y; Harada M; Kaji R
Neurol Sci; 2021 Oct; 42(10):4257-4263. PubMed ID: 33594539
[TBL] [Abstract][Full Text] [Related]
60. Functional limitation of the masticatory system in patients with bulbar involvement in amyotrophic lateral sclerosis.
Riera-Punet N; Martinez-Gomis J; Willaert E; Povedano M; Peraire M
J Oral Rehabil; 2018 Mar; 45(3):204-210. PubMed ID: 29240971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
